Huang, Ping HanPing HanHuangTsai, Hsiao HanHsiao HanTsaiLiao, Bo HungBo HungLiaoLin, Yi LingYi LingLinJan, Jia TsrongJia TsrongJanTao, Mi HuaMi HuaTaoChou, Yu ChiYu ChiChouHu, Che Ming JackChe Ming JackHuHUI-WEN CHEN2023-06-082023-06-082021-01-0121645515https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091731587&doi=10.1080%2f21645515.2020.1814098&partnerID=40&md5=01d87b619796e6c6511e2e864dbb108bhttps://scholars.lib.ntu.edu.tw/handle/123456789/631975A safe and effective vaccine candidate is urgently needed for the ongoing COVID-19 pandemic, caused by SARS-CoV-2. Here we report that recombinant SARS-CoV-2 RBD protein immunization in mice is able to elicit a strong antibody response and potent neutralizing capability as measured using live or pseudotyped SARS-CoV-2 neutralization assays.enneutralizing antibodies; receptor-binding domain; SARS-CoV-2; vaccine[SDGs]SDG3other10.1080/21645515.2020.1814098329912312-s2.0-85091731587WOS:000573652300001https://api.elsevier.com/content/abstract/scopus_id/85091731587